CHMP recommends four new medicines, including first-in-class treatment for follicular lymphoma
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticalsProduct LifecycleRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticalsProduct Lifecycle